-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Advantages of Humanized Models of the Immune System
Author:
InnoModels
Release time:
2024-04-22
With the rapid development of the biomedical field, understanding the function of the immune system and disease mechanisms has become an important prerequisite for disease diagnosis and treatment. As an advanced biomedical research tool, the humanized model of the immune system is helping us to gain a deeper understanding of the complexity and diversity of the human immune system, and advancing the progress of medical research.
What is the Genomics Humanized Model of the Immune System?
The Humanized Immunity System Model, or HIS model for short, is an experimental model based on gene editing and cell engineering technologies. The model introduces key components of the human immune system (e.g., immune cells, immune-related genes, etc.) into experimental animals so that they have functions and responses similar to those of the human immune system. This model is able to simulate the response of the human immune system under various physiological and pathological conditions, providing a powerful tool for the study of immune-related diseases.
Advantages of InnoModels' humanized model of the immune system
1. Highly humanized: the humanized model of the biomimetic immune system is highly similar to the human immune system in terms of immune cell types, immune-related gene expression and regulation, and therefore can more accurately reflect the biological characteristics of the human immune system.
2. High controllability: Through gene editing technology, researchers can precisely manipulate the immune cells in the model, such as regulating gene expression and altering cell function. This controllability enables researchers to gain a deeper understanding of the functional mechanisms of the immune system and the disease process.
3. Wide scope of application: The InnoMod Bioimmune System Humanized Model can be applied to the study of a variety of immune-related diseases, such as autoimmune diseases, infectious diseases, tumors and so on. In addition, the model can also be used for drug screening and immunotherapy strategy development.

Prospects for the application of the InnoModels Bioimmune System Humanized Model
The humanized model of biomimetic immune system has a broad application prospect in the field of biomedical research. With the continuous development and improvement of the technology, the model will play an important role in the following aspects:
1. Disease mechanism research: By simulating the function and response of the human immune system, the humanized model of the biomimetic immune system can help to reveal the pathogenesis of immune-related diseases and provide new ideas and methods for disease diagnosis and treatment.
2. Drug discovery and development: The humanized model of the modeling bioimmune system can be used as an important tool for drug screening and evaluation, helping researchers to identify potential drug candidates and assess their effects and safety in vivo.
3. Research and development of immunotherapeutic strategies: The model can be used to study the effectiveness and safety of immunotherapeutic strategies, such as immune cell therapy and immunomodulatory drugs. By optimizing immunotherapy strategies, it is expected to improve the treatment effect of the disease and the quality of life of patients.
Summary and Prospect
As a revolutionary tool in the field of biomedical research, the InnoModels Bioimmune System Humanized Model provides us with powerful support for a deeper understanding of the complexity and diversity of the human immune system. With the continuous development and improvement of the technology, the model will play an increasingly important role in the study of disease mechanisms, drug discovery and development of immunotherapy strategies. In the future, we have reason to believe that the humanized model of the immune system will become an important force in medical research and therapeutic technology innovation.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd